Literature DB >> 3549719

Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family.

P N Benfey, F H Yin, P Leder.   

Abstract

We have isolated, cloned, and characterized cDNA and genomic DNA corresponding to the mRNA and gene for the rat mast cell protease, RMCP II. The amino acid sequence deduced from the cDNA provides evidence that this protease is synthesized as a precursor, with a signal peptide and additional residues at the N and C termini. RNA homologous to the cDNA is expressed only in mast cells. Analysis of RNA from the two subclasses of mast cell, mucosal and serosal, indicates subclass specific expression of the different proteases found in each of these two subclasses. S1 protection analysis and the sequence of the genomic clone indicate that the serosal mast cell protease, RMCP I, is likely to be coded for by a separate, highly homologous gene. A comparison of the exon/intron structure of the RMCP II gene with genes of related serine proteases further indicates that RMCP II is a member of a family of proteases distinct from those found in the pancreas. We have also isolated a third gene, highly homologous to RMCP II but different from it and from the gene for RMCP I. Analysis of the 5' transcriptional control region of both genes showed striking homology to the TATA box and enhancer regions of the pancreatic proteases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549719

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Regulation and function of mast cell proteases in inflammation.

Authors:  C Huang; A Sali; R L Stevens
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

2.  Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution.

Authors:  Maike Gallwitz; Lars Hellman
Journal:  Immunogenetics       Date:  2006-06-29       Impact factor: 2.846

3.  Cloning of the cDNA and nucleotide sequence of a skeletal muscle protease from myopathic hamsters.

Authors:  J C Holt; V B Hatcher; J B Caulfield; P Norton; P K Umeda; J A Melendez; L Martino; S P Mudzinsky; F Blumenstock; H S Slayter; S S Margossian
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

4.  Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.

Authors:  D Campanelli; P A Detmers; C F Nathan; J E Gabay
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cDNA.

Authors:  S Avraham; R L Stevens; C F Nicodemus; M C Gartner; K F Austen; J H Weis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 6.  Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

Authors:  A Rouleau; V Dimitriadou; M D Trung Tuong; G F Newlands; H R Miller; J C Schwartz; M Garbarg
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Identification and sequencing of cDNA clones encoding the granule-associated serine proteases granzymes D, E, and F of cytolytic T lymphocytes.

Authors:  D Jenne; C Rey; J A Haefliger; B Y Qiao; P Groscurth; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.

Authors:  H Urata; K D Boehm; A Philip; A Kinoshita; J Gabrovsek; F M Bumpus; A Husain
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

Authors:  G Pejler; K Söderström; A Karlström
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

10.  CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity.

Authors:  H A Pereira; W M Shafer; J Pohl; L E Martin; J K Spitznagel
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.